Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| 1-[2-[(1R,3S,5R)-3-[[(1S)-1-(3-Chloro-2-fluorophenyl)ethyl]carbamoyl]-2-azabicyclo[3.1.0]hexan-2-yl]-2-oxoethyl]pyrazolo[3,4-c]pyridine-3-carboxamide | IC50 | 29.0 [1], 30.0 [2], 70.0 [3], 144.0 [4] | |
| Methyl (S)-2-((2-((3-(trifluoromethoxy)phenyl)carbamoyl)pyrrolidine-1-carboxamido)-methyl)benzoate | IC50 | 14000.0 [1] | |
| Danicopan | IC50 | 4.0 [1], 15.0 [2] | |
| (1R,3S,5R)-3-N-(6-Bromopyridin-2-yl)-2-N-(1-carbamoylindol-3-yl)-2-azabicyclo[3.1.0]hexane-2,3-dicarboxamide | IC50 | 5.0 [1], 6.0 [2], 9.0 [3] | |
| (2S)-N-(6-Bromopyridin-2-yl)-3-[2-(3-carbamoylpyrazolo[3,4-b]pyridin-1-yl)acetyl]-1,3-thiazolidine-2-carboxamide | IC50 | 19.0 [1], 27.31 [2], 205.0 [3] | |
MLA | "Quest Database™ Complement factor D Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 19 Dec. 2025, https://www.aatbio.com/data-sets/complement-factor-d-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 19). Quest Database™ Complement factor D Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/complement-factor-d-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |